Increased Sales Costs Keep Lid on Earnings August 21, 2007 -- China Shenghuo Pharmaceutical Holdings, Inc. (KUN) reported greatly improved numbers for its second quarter. Compared to the year earlier, revenues for the company jumped 52% to $6.4 million, while net income climbed 29% to $1.3 million. In the second quarter, gross margin moved up from 63% to 75%. But increased costs, especially for sales and marketing, kept some of the increases from moving to the bottom line. More details...
